全文获取类型
收费全文 | 28077篇 |
免费 | 2567篇 |
国内免费 | 2097篇 |
专业分类
耳鼻咽喉 | 316篇 |
儿科学 | 242篇 |
妇产科学 | 279篇 |
基础医学 | 3081篇 |
口腔科学 | 362篇 |
临床医学 | 3510篇 |
内科学 | 3754篇 |
皮肤病学 | 231篇 |
神经病学 | 1495篇 |
特种医学 | 946篇 |
外国民族医学 | 9篇 |
外科学 | 3224篇 |
综合类 | 5702篇 |
现状与发展 | 4篇 |
预防医学 | 1846篇 |
眼科学 | 736篇 |
药学 | 3213篇 |
23篇 | |
中国医学 | 1703篇 |
肿瘤学 | 2065篇 |
出版年
2024年 | 90篇 |
2023年 | 398篇 |
2022年 | 1057篇 |
2021年 | 1238篇 |
2020年 | 1011篇 |
2019年 | 848篇 |
2018年 | 827篇 |
2017年 | 812篇 |
2016年 | 768篇 |
2015年 | 1179篇 |
2014年 | 1424篇 |
2013年 | 1439篇 |
2012年 | 2192篇 |
2011年 | 2063篇 |
2010年 | 1512篇 |
2009年 | 1233篇 |
2008年 | 1478篇 |
2007年 | 1557篇 |
2006年 | 1571篇 |
2005年 | 1510篇 |
2004年 | 1190篇 |
2003年 | 1290篇 |
2002年 | 1101篇 |
2001年 | 914篇 |
2000年 | 790篇 |
1999年 | 708篇 |
1998年 | 357篇 |
1997年 | 398篇 |
1996年 | 286篇 |
1995年 | 275篇 |
1994年 | 215篇 |
1993年 | 143篇 |
1992年 | 159篇 |
1991年 | 135篇 |
1990年 | 140篇 |
1989年 | 101篇 |
1988年 | 79篇 |
1987年 | 88篇 |
1986年 | 56篇 |
1985年 | 47篇 |
1984年 | 22篇 |
1983年 | 17篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 3篇 |
1979年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
蛋白酶对降低异常精液粘稠度的实验对比研究 总被引:1,自引:0,他引:1
目的通过不同蛋白酶类对降低高粘稠度精液的粘稠度效果对比,寻找理想的降低精液粘稠度的药物。方法将高粘稠度精液标本分为两组,A组:31例采用α-糜蛋白酶降低精液粘稠度:B组:32例采用尿激酶降低精液粘稠度;两组均观察用药前后的精子活动力。采用配对t检验和单因素方差分析对所得数据作统计学处理。结果高粘稠度精液用药物(α-糜蛋白酶或者尿激酶)液化精液后,精子的活动力较用药前有明显提高(P<0.001);用药前后精液的粘稠度都存在着明显的差异,精液的粘稠度分别下降44.83%和55.45%(P<0.001);在A组和B组的对比研究中,单因素方差分析检验提示:用药后两组间粘稠度数据有显著的差异(P<0.001£(?)。结论蛋白酶可以有效地降低异常精液粘稠度的精液,从实验结果提示尿激酶降低精液粘稠度的效果优于α-糜蛋白酶,这有助于临床开展应用性研究和治疗。 相似文献
32.
TCD观察动脉瘤性SAH后脑血管痉挛的血流动力学改变 总被引:4,自引:0,他引:4
目的探讨动脉瘤性蛛网膜下腔出血(SAH)后脑血管痉挛的血流动力学改变。方法经CT、DSA证实为动脉瘤性SAH患者179例,床旁经颅超声多谱勒(TCD)在术前、术后1~3d、5~7d、9~11d、12~14d记录并分析大脑中动脉(M CA)的血流参数及频谱改变。结果M CA平均血流速度(Vm)于SAH后1~3d开始升高,5~7d、9~11d达到高峰;L I(血管痉挛指数)为3~6时预后良好;>6时可以出现神经系统功能损害,颅内压增高且有脑血管痉挛(CV S)者预后较差。结论TCD能无创、实时评价SAH后CV S的动态变化,可以推断SAH后CV S的严重程度及临床转归。 相似文献
33.
目的:探讨大肠癌术后早期炎性肠梗阻的特点及治疗方法;方法:分析10例大肠癌术后出现早期炎性肠梗阻的临床表现并进行综合保守治疗;结果:10例患者保守治疗全部成功;结论:术后早期炎性肠梗阻是一种非细菌性炎性肠梗阻,以发生在术后早期,腹胀、呕吐明显,腹痛轻或无为主要临床特点,治疗应采用保守治疗。 相似文献
34.
Association of the expressions of platelet-derived growth factor receptor and c-Fos with the biological characteristics of bladder cancer. 总被引:1,自引:0,他引:1
OBJECTIVE: To elucidate the relation of platelet-derived growth factor receptor (PDGFR) and c-Fos protein expressions with human bladder transitional epithelial cell carcinoma (BTCC). METHODS: The expressions of PDGFR and c-Fos were investigated in 11 normal bladder tissue samples, 14 adjacent non-carcinoma tissues and 43 BTCC tissues by means of SP immunohistochemical technique. RESULTS: The c-Fos expression was found in the cell nuclei and cytoplasm, and PDGFR in the nuclear membrane, cytoplasm, and cellular membrane. PDGFR and c-Fos were detected in 81.40% and 48.83% of the BTCC tissues respectively, at the rates both significantly higher than those in normal and adjacent non-carcinoma tissues (P<0.05). Correlation between the expression of c-Fos and the tumor grading was noted (P<0.05). The expressions of PDGFR and c-Fos in tumor blood vessels were significantly higher than those in normal vessels. CONCLUSIONS: The expressions of PDGFR and c-Fos might be involved in the development of BTCC, possibly related to the angiogenesis of the tumors. c-Fos expression can indicated the cell proliferative status of the BTCC. 相似文献
35.
甲醛固定源同种异体骨移植材料的体外实验研究 总被引:5,自引:0,他引:5
Yun-tao Lu Lin Yuan Pei-feng Jiao Lei Yu Xiao-zhong Qiu Li-sheng Zhang Shi-zhen Zhong 《第一军医大学学报》2004,24(1):27-31
OBJECTIVE: To conduct an in vitro study to assess the preliminary possibility of using formalin-fixed, instead of fresh, human bone tissues for allografting. METHODS: Fresh cadaveric bone tissues were fixed by formalin for more than 6 months and dissected into 5 mmx5 mmx5 mm pieces and 5 mmx5 mmx40 mm sticks, followed by chemical treatments to prepare the allograft bone materials. When alls treatments were completed, the bone grafts were centrifuged and their properties and cellular compatibility assessed in comparison with the currently used bone grafts clinically. RESULTS: The residual formaldehyde of the fixed allograft bone material was much below the controlled level and no significant differences were noted between the bone graft materials tested in regard to the chemical and mechanical properties and biocompatibility. CONCLUSION: This material we have prepared may meet the clinical demands for bone grafting, with good biocompatibility and less chance for infection by pathological agents. 相似文献
36.
Zhong Q. Wang Audrey D. Bell-Farrow William Sonntag William T. Cefalu 《Experimental gerontology》1997,32(6):E966-684
We report on the effect of age and chronic caloric restriction (CR) on insulin binding and glucose transporter content in both diaphragm and heart muscle membrane of young (11 months), mid-age (17 months), and old (29 month) ad libitum fed and CR Brown-Norway rats. The control animals received rat chow ad lib and CR animals were allowed 60% of ad libitum food. The CR regimen was initiated at four months of age and the animals were maintained on their respective diets until necropsy. There was no effect of age on insulin binding for either ad libitum or CR animals at each age evaluated. Caloric restriction significantly lowered insulin levels at each age studied when compared to the ad libitum-fed rats. However, CR animals were noted to have increased insulin binding (p < 0.001) compared to ad libitum-fed animals at each age for diaphragm muscle. For the heart, there appeared to be a decreased binding, particularly at higher insulin concentrations, in CR-fed animals. There was no net change in Glut-1 or Glut-4 levels for heart muscle membrane, or Glut-4 levels for diaphragm muscle membrane between ad libitum or CR animals. This data indicates that caloric restriction may have tissue-specific effects for insulin receptor binding, and that the improved insulin sensitivity in CR states is not a result of altered glucose transporter protein content. 相似文献
37.
对173例支气管哮喘特异性脱敏治疗的疗效及影响疗效的因素进行了分析。结果表明:显效为30.6%(53/173).有效为56.1%(97/173),无效为13.3%(23/173)。影响疗效的因素与病情的程度有关,而与年龄、病程、皮试阳性反应强弱及脱敏治疗前4个疗程内是否应用曲安缩松等无关。并对特异性脱敏治疗支气管哮喘的优缺点进行讨论。 相似文献
38.
39.
The synthesis of 15 possible metabolites of prolintane (1) (Katovit) which is used in the treatment of blood pressure disregulations is described. Furthermore, the preparation of the enantiomers of 1 is reported, starting with R-(+)- and S-(-)-phenylalaninol respectively. 相似文献
40.
益气平喘丸的药理研究 总被引:7,自引:0,他引:7
本实验结果表明,益气平喘丸具有明显的平喘止咳祛痰作用,并能显著增加免疫低下小鼠的免疫器官重量及碳粒廓清速率,使正常大鼠血清皮质醇浓度显著升高及肾上腺内维C 含量明显降低。 相似文献